DEVENTER, Netherlands, Aug 25, 2026 – 819 Capital Partners has acquired BEDROCK 3D and will place the company under Novio-Scan Holding, the group that consolidates its 3D printing businesses. BEDROCK 3D produces filaments for professional 3D printing applications, adding a materials arm to a group that spans hardware, software, and end-use applications.
The Novio-Scan group also owns Insolution, which supplies 3D printers to podiatrists to produce custom insoles. Insolution bundles its machines with 3D scanning, proprietary software, and materials, and uses both traditional milling and its own 3D printing technology. Insolution’s systems use BEDROCK 3D filament, linking material production with finished-product manufacturing within the group.
BEDROCK 3D plans to expand its operations. Novio-Scan will continue evaluating companies and technologies in the 3D printing market.
Source: BEDROCK 3D
About BEDROCK 3D
BEDROCK 3D produces polymer filaments for fused filament fabrication, or FFF, 3D printers. Founded in 2013 as Innofil3D, it launched the BEDROCK 3D brand in 2025. The company is based in Emmen, Netherlands, and operates through Forward AM Technologies Netherlands B.V. Its portfolio includes standard, flexible and engineering-grade materials, including PLA, PET, ABS, PP, TPU and filled filaments. The materials are used for prototypes, fixtures, end-use parts, medical insoles and other FFF applications. Customers include printer manufacturers, distributors, resellers, print farms, industrial users, designers and individual makers. BEDROCK 3D sells through distributors and resellers in Europe, South America and Africa. It provides technical data sheets, safety data sheets, print profiles and customer support. It lists ISO 9001 certification.
About 819 Capital Partners
819 Capital Partners is a Dutch investment firm that provides venture capital, private equity, mergers and acquisitions advisory, and valuation services. The firm launched in 2023 and operates from Deventer and Hoofddorp, Netherlands. 819 manages the 819 Evergreen Fund and private equity funds. It invests in early-stage companies, established businesses and buy-and-build platforms. Its portfolio includes companies in health care, technology, leisure, medical technology, biotechnology, advanced materials and AI. Clients include investors, founders, management teams, portfolio companies and companies seeking M&A or valuation advice. The firm reports more than €100 million in assets under management and 42 portfolio companies. Those companies report more than €500 million in revenue and more than 1,000 employees.
